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We have characterized a phosphoprotein protein with a death effector domain that has a novel bifunctional role in
programmed cell death. The 15-kDa phosphoprotein enriched in astrocytes (PEA-15) inhibits Fas-mediated apoptosis and
increases tumor necrosis factor receptor-1 (TNF-R1)-mediated apoptosis in the same cell type in a ligand-dependent manner.
Phosphorylation appears to play a role in its differential effects, since point mutations at one or both phosphorylation
consensus sites within PEA-15 destroy its effect on Fas-mediated, but not TNF-R1-mediated, apoptosis. Furthermore, the
differential effect is evident at the level of caspase-8 activity which is inhibited via Fas activation, but increased via TNF-R1
activation upon PEA-15 expression. These results show that PEA-15 provides a potential mechanism during development
for distinguishing between diverse extracellular death-inducing signals that culminate either in apoptosis or in
survival. © 1999 Academic PressKey Words: apoptosis; Fas; TNF-a; phosphoprotein; death effector domain; caspase.
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(INTRODUCTION
Apoptosis, or programmed cell death, plays a major role
in embryonic development and tissue homeostasis. Extra-
cellular signals activate cell death receptors, such as CD-95
(Fas/Apo-1) and tumor necrosis factor receptor-1 (TNF-R1).2
Differences in survival of diverse cell types upon exposure
to activators of these two receptors are well known, al-
though most cells appear to harbor similar effector compo-
nents (Weil et al., 1996). Thus, mechanisms must exist
whereby cells can discriminate between diverse death-
inducing signals in the environment. Such mechanisms are
1 To whom correspondence should be addressed. Fax: (650) 725-
2952. E-mail: hblau@cmgm.stanford.edu.
2 Abbreviations used: CaMKII, calcium calmodulin kinase II;
-FLIP, cellular FLICE-inhibitory protein; CrmA, cytokine re-
ponse modifier A; DD, death domain; DED, death effector domain;
ISC, death-inducing signaling complex; FACS, fluorescence-
ctivated cell sorting; FADD, Fas-associated death domain protein;
ST, glutathione S-transferase; IPTG, isopropyl-1-thio-b-D-galac-
topyranoside; IRES, internal ribosomal entry site; PEA-15, 15-kDa
phosphoprotein enriched in astrocytes; PE, phycoerythrin; PI, pro-t
t
pidium iodide; PKC, protein kinase C; TNF-a, tumor necrosis
actor-a; TNF-R1, tumor necrosis factor receptor-1.
16ikely to play a critical role in physiological cell death in the
ourse of development.
Apoptosis is mediated by conserved pathways that in-
lude numerous activators, effectors, and inhibitors (Na-
ata, 1997). TNF-R1 and Fas (CD95/APO-1) are two distinct
embrane-associated death receptors which induce apopto-
is upon interaction with extracellular ligands (TNF-a or
as ligand, respectively) or antibodies that mimic ligand
timulation (for example, anti-Fas antibody) (Itoh et al.,
991; Tartaglia et al., 1993). TNF-R1 and Fas are character-
zed by the presence of a conserved death domain (DD)
ithin the cytoplasmic region. Stimulation of death recep-
ors results in aggregation of DDs which leads to recruit-
ent of signaling proteins such as the Fas-associated death
omain protein (FADD/Mort1) (Boldin et al., 1995; Chin-
aiyan et al., 1995). These proteins also contain C-terminal
Ds through which they oligomerize with the receptors to
orm what has been named in the case of Fas, the death-
nducing signaling complex (DISC) (Kischkel et al., 1995).
n addition, they have an N-terminal death effector domain
DED) that recruits a protease known as pro-caspase-8
FLICE/Macha1) (Boldin et al., 1996; Muzio et al., 1996)
hrough homologous interaction between one or both of
wo DEDs on pro-caspase-8. Caspase-8, the first zymogen of
0012-1606/99 $30.00
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17Opposite Effects on Apoptosis via Two Death Receptorsthe caspase cascade, is a common focal point in both Fas
and TNF-R1 cell death pathways.
Close proximity of pro-caspase-8 molecules induces an
intrinsic low-level enzyme activity that results in auto-
cleavage of pro-caspase-8 to its active form and release from
the membrane to the cytoplasm where it initiates a caspase
cascade sequentially converting inactive zymogens to ac-
tive proteases (Medema et al., 1997). The latter act on
specific substrates, eventually resulting in changes charac-
teristic of apoptotic cell death: DNA fragmentation, mem-
brane blebbing, cell condensation and rounding, and loss of
adherence to substrate. Thus, a series of homophilic inter-
actions leads to the assembly of the death machinery by an
“induced proximity model,” a mode of signaling unique to
apoptosis (Muzio et al., 1998).
A 15-kDa phosphoprotein enriched in astrocytes (PEA-15)
has recently been shown to be expressed ubiquitously in
mice, both as mRNA and as protein, albeit at lower levels
than in astrocytes. Indeed, PEA-15 mRNA is abundant as
early as embryonic day 12 (Estelle´s and Blau, unpublished
results). Changes in the phosphorylation state of PEA-15 in
response to hormones and neurotransmitters have previ-
ously suggested that phosphorylation may be important to
the function of this protein (Araujo et al., 1993; Kubes et al.,
1998). Although PEA-15 was recently found to have a DED
domain (Boldin et al., 1996; Muzio et al., 1996), the physi-
ological role of PEA-15 and the significance of its phosphor-
ylation state remain unclear.
In this report, we show that PEA-15 can function in two
different ways in the same cell type, enhancing apoptosis
via the TNF-R1 cell death pathway or inhibiting apoptotic
signaling via Fas activation. Studies of PEA-15 with muta-
tions at the consensus phosphorylation sites suggest that its
phosphorylation status is critical to its ability to distin-
guish between promotion of or protection from cell death.
In both pathways PEA-15 affects caspase-8, the first enzyme
in the caspase cascade, either inhibiting or enhancing
enzyme activity depending on which receptor is activated.
Although the precise mechanism of activation remains to
be elucidated, PEA-15 differs from other proteins involved
in apoptosis described to date in that its intracellular
expression provides a means by which a cell can respond
differently to extracellular apoptotic stimuli that act via
two different cell death pathways.
MATERIAL AND METHODS
Tissue Culture
NIH-3T3 cells (3T3) were obtained from ATCC and cultured in
DME (Gibco BRL, Gaithersburg, MD) supplemented with 10% calf
serum (Hyclone, Logan UT). Phoenix-E cells were provided by Dr.
G. Nolan (Stanford University) and cultured in DME high glucose
(Gibco) and 10% FBS (Hyclone). Human recombinant tumor necro-
sis factor-a (TNF-a) was purchased from R&D (Minneapolis, MN).
Cycloheximide, staurosporine, isopropyl-1-thio-b-D-galactopy-
ranoside (IPTG), and propidium iodide (PI) were obtained from
Sigma (St. Louis, MO). The Jo2 antibodies (mouse anti-Fas and
Copyright © 1999 by Academic Press. All rightmouse anti-Fas coupled to phycoerythrin (PE)) were obtained from
PharMingen (San Diego, CA).
Plasmid Construction
Murine PEA-15 cDNA was amplified by PCR using the original
full-length cDNA isolated from an astrocytic cDNA library, G11
(Estelle´s et al., 1996), as template and subsequently cloned into the
TA cloning vector PCR2.1 (Invitrogen, Carlsbad, CA). The 59-
primer was designed to introduce an NcoI site at the ATG (59-GCG
CCA TGG CAG AGT ACG GAA CTC TCC-39) and the 39-primer
introduced a BamHI site downstream of the stop codon (59-GCG
GGA TCC TCA GGC CTT CTT TGG TGG GGG-39). The
sequence of the cloned PCR product was verified by sequencing. A
myc tag oligonucleotide was added to the N-terminus using the
NcoI site. The NcoI–BamHI myc–PEA-15 fragment was then
cloned into the same sites of pGEM– internal ribosomal entry site
(IRES) (kindly provided by Dr. G. Nolan, Stanford University)
downstream of a mengo-derived internal ribosomal entry site
sequence to give rise to pGEM–IRES–myc–PEA-15. The retroviral
b-glucuronidase (GUS) expression vector, pBabe–M-GUS, was gen-
erated in our laboratory and kindly provided by Dr. A. Hofmann for
these studies. An EcoRI–SalI fragment (containing the IRES–myc–
PEA-15 unit) of pGEM–IRES–myc–PEA-15 was cloned into the
same sites of pBabe–M-GUS to generate the retroviral vector
pBabe–M-GUS– IRES–myc–PEA-15. The retroviral vector pBabe–
M-GUS–IRES–Fas encoding murine Fas was obtained from Dr. A.
Hofmann. To generate PEA-15 phosphorylation mutants, the Cha-
meleon site-directed mutagenesis kit (Stratagene, La Jolla, CA) was
used on the G11 cDNA (Estelle´s et al., 1996), and the same strategy
utlined above for pBabe–M-GUS–IRES–myc–PEA-15 was used to
btain retroviral vectors expressing the phosphorylation defective
utants. The retroviral vector PFEV–flag-FADD was generated by
nserting the flag-FADD cDNA from pRK5–flag-FADD (obtained
rom Dr. D. Goeddel, Tularik, South San Francisco, CA) as a
amHI–NotI fragment in PFEV (generated in our laboratory from a
Babe backbone and obtained from P. Feng). pBabe–CrmA–
uromycin was kindly donated by Dr. J. Yuan (Harvard University).
Babe M-FLICE and pBabe M-FADD were kindly donated by Dr. Y.
itoshi (Rigel, South San Francisco, CA). MSCV–Bcl-2–PGK–Puro
as kindly donated by Dr. G. Nolan (Stanford University). GST–
EA-15 was cloned as a BamHI–XhoI fragment from the G11
cDNA (Estelle´s et al., 1996) into pGEX-5X-3 (Pharmacia, Piscat-
away, NJ). GST– FADD was generated by inserting PCR-amplified
FADD (not containing the flag tag) as a BamHI–SalI fragment from
pRK5–flag-FADD into pGEX-4T-1 (Pharmacia, Piscataway, NJ).
The 59-primer was designed to introduce a BamHI site at the ATG
(59-GCG GGA TCC GCC ACC ATG GAC CCA TTC CTG
GTG-39) and the 39-primer a SalI site downstream of the stop codon
(59-CGC GTC GAC TCA AGT CCA CAG TGA CTG-39). The
sequence of the cloned PCR product was verified by sequencing.
Fluorescence-Activated Cell Sorting (FACS)
Analysis
For analysis of Fas expression, cells were detached from the dish
by incubating in PBS containing 1 mM EDTA. Cells in suspension
were incubated in FACS buffer (PBS/4% FBS) containing the mouse
anti-Fas antibody, Jo2, coupled to PE according to the manufac-
turer’s recommendations (PharMingen). Cells were then rinsed
several times in FACS buffer and analyzed for PE using a FACScan
(Becton Dickinson, Franklin Lakes, NJ). For GUS expression, cells
s of reproduction in any form reserved.
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18 Estelle´s, Charlton, and Blauwere trypsinized in order to detach the cells from the dish,
resuspended in FACS buffer, and incubated with the fluorescent
substrate fluorescein di-b-D-glucuronide (Molecular Probes, Eu-
gene, OR) as previously described (Nolan et al., 1988).
Production of Retrovirus and Viral Transduction
Retroviral particles were produced by transiently transfecting
the packaging cell line Phoenix-E using Fugene 6 according to the
manufacturer’s recommendations (Boehringer Mannheim, India-
napolis, IN). 3T3 cells were transduced as previously described
(Springer and Blau, 1997).
Immunoprecipitations, Western Blot Analyses,
and 2-D Gels
Rabbit anti-PEA-15 polyclonal antibodies were generated against
the C-terminus of the molecule (RQPSEEEIIKLAPPPKK) (BABCO,
Berkeley, CA).
Stable cell lines constitutively expressing different components
of the apoptotic pathways were obtained as cited above. Cells
plated in 15-cm dishes were treated with apoptotic inducers (100
ng/ml or 1 mg/ml of anti-Fas antibody or 10 ng/ml TNF-a (no
cycloheximide was used in immunoprecipitations)) or left un-
treated for 15 min, 1 h, 3 h, or 6 h. Cells were rinsed with PBS and
lysed in 1 ml of lysis buffer containing 20 mM Tris, pH 7.5, 140
mM NaCl, 1 mM EDTA, 1% NP-40, 50 mM NaF, 2 mM NaPPi, 0.2
mM Na orthovanadate, and a cocktail of protease inhibitors (Com-
plete, Boehringer Mannheim) on ice for 30 min. For immunopre-
cipitation, postnuclear lysates were incubated with Sepharose
beads (30 ml beads/ml lysate) coupled to myc (BABCO) or flag
antibodies (Sigma) or protein G–Sepharose beads for 3 h at 4°C, and
immunoprecipitates were then washed four times in lysis buffer.
Immunoprecipitates and whole cell lysates were boiled in SDS
sample buffer and resolved by PAGE on 4–15% gradient gels.
Proteins were transferred to Immobilon membranes (Amersham,
Arlington Heights, IL) and detected by Western blotting using
anti-flag, myc, or PEA-15 antibodies (described above) diluted
1:1000.
For two-dimensional gel electrophoresis, whole cell lysates were
quantitated and isoelectric focusing was carried out using 2% pH
4–8 ampholines (Kendrick Laboratories, Madison, WI). The second
dimension was resolved by PAGE on 12.5% gels. Parallel gels were
silver stained and transferred to membrane for Western blotting
with anti-myc antibodies.
Caspase-8 Activity Assays
Stable cells lines constitutively expressing different components
of the apoptotic pathways were obtained as cited above. Cells
plated in 10-cm dishes were treated for 0, 3, 4.5, or 6 h with
apoptotic inducers (100 ng/ml of anti-Fas antibody or 10 ng/ml
TNF-a concomitant with 10 mg/ml of cycloheximide) or treated
ith cycloheximide alone. Total protein lysates were quantitated
nd caspase-8 activity from 150 mg of total protein was measured by
sing the ApoAlert caspase-8 colorimetric assay kit (Clontech, Palo
lto, CA) that uses the caspase-8 inhibitor IETD (Garcia-Calvo et
l., 1998) according to the recommendations of the manufacturer.
Copyright © 1999 by Academic Press. All rightPreparation of Glutathione S-Transferase (GST)
Fusion Proteins and GST-Binding Reactions
GST fusion proteins were prepared from BL21 (Stratagene) bac-
terial lysates. Bacteria carrying the plasmids were grown in Luria–
Bertani medium and the fusion proteins were induced with IPTG
(Sigma). Bacteria were pelleted and lysed in PBS by three cycles of
freezing/thawing. Debris was removed by centrifugation at
14,000g. Bacterial lysates were incubated at room temperature with
glutathione–Sepharose beads (Pharmacia; Piscataway, NJ; 1 ml
beads/liter culture), washed, and resuspended in PBS. Total lysates
from 3T3 cells were obtained as described above and incubated
with the GST, GST–PEA-15, or GST–FADD beads for 3 h at 4°C.
Beads were washed four times in lysis buffer, boiled in SDS sample
buffer, and resolved by PAGE on 4–15% gradient gels. Proteins
were transferred to Immobilon membranes and detected by West-
ern blotting using anti-flag, myc, PEA-15, or caspase-8 antibodies.
NF-kB Reporter Assays
An oligonucleotide containing the IgG-k–NF-kB site (sequence
59-GGGGACTTTCC-39) was placed upstream of a minimal IL-8
promoter (position 267 to 144) in a luciferase reporter gene
construct and transiently transfected into 3T3–GUS or 3T3–
PEA-15 cells. Cells were treated 24 h after transfection with 10
ng/ml human TNF-a. After 6 h, cells were lysed, and postnuclear
ysates were standardized for equal protein concentration. Lucif-
rase activity was measured by using a luciferase assay kit (Pro-
ega, Madison, WI), according to the recommendations of the
anufacturer, and a luminometer (Analytical Luminescence Lab-
ratory, San Diego, CA)
Assays for Apoptosis
Cells were plated in 35-mm dishes (105 cells) the day prior to the
xperiment. After 4 h of exposure to the apoptotic stimuli (100
g/ml of anti-Fas antibody in the presence of 10 mg/ml of cyclo-
eximide, 10 ng/ml TNF-a also in the presence of 10 mg/ml of
ycloheximide, or 0.2 mM staurosporine), cells were rinsed with
PBS and incubated overnight with fresh medium. Floating as well
as adherent cells were recovered, pelleted by low speed centrifuga-
tion, and resuspended in FACS buffer containing PI. Ten-thousand
cells were analyzed by FACS for PI incorporation. To verify that
PI-positive cells correlated with apoptotic cells, a sensitive ELISA
was performed to detect histone-associated DNA fragments (cell
death detection ELISA, Boehringer Mannheim) according to the
recommendations of the manufacturer.
RESULTS
PEA-15 Expression Increases Sensitivity of 3T3
Cells to Apoptosis Induced by TNF-a
NIH-3T3 cells express p55 TNF-R1 and undergo
apoptosis upon treatment with TNF-a in the presence of
protein synthesis inhibitors (Fig. 1). To study the role of
PEA-15 in TNF-a-induced apoptosis, cells were geneti-
cally engineered using retroviral vectors to express myc-
tagged PEA-15 at higher levels than the endogenous
PEA-15. These were distinguishable by Western blot
using anti-PEA-15 antibodies. Constitutive expression of
s of reproduction in any form reserved.
c
m
P
P
l
c
a
f
b
a
c
s
o
s
c
e
P
C
t
e
p s for
d
19Opposite Effects on Apoptosis via Two Death Receptorsmyc–PEA-15 resulted in 20-fold higher levels of the
protein (Fig. 2D, top). In three independent experiments
with quadruplicate samples, upon exposure to TNF-a,
onstitutive expression of PEA-15 resulted in fivefold
ore cell death than was observed in controls lacking
EA-15 (Fig. 2A). The enhanced apoptotic effect of
EA-15 on TNF-a-treated cells was assayed by FACS
measurement of PI fluorescence, an indicator of plasma
membrane integrity. The incorporation of PI as a measure
of cell death was corroborated by another assay charac-
teristic of apoptosis, an ELISA that detects release of
histone/DNA complexes, a measurement of DNA frag-
mentation (Thome et al., 1997; Estelle´s and Blau, unpub-
ished observations). In addition, the morphology of the
ells further confirmed that they were dying in a typically
poptotic manner, with membrane blebbing, detachment
rom the dish, and disintegration into small apoptotic
odies (Fig. 1). The PEA-15 effect on TNF-a-induced
poptosis involved activation of caspases, possibly
aspase-8, since the effect was completely blocked in
table cell lines transduced to express the viral inhibitor
FIG. 1. Effect of PEA-15 on TNF-R1-mediated cell death. Both
enhance apoptosis in response to TNF-a treatment. Control 3T3 c
phosphorylation-defective PEA-15 mutant, M3 (S104A&S116A) (ro
rotein synthesis inhibitor, cycloheximide. Prior to harvesting cell
ocument effects on cell death.f caspases, CrmA (Fig. 2B). Since, as in many other
tudies of apoptosis, cycloheximide alone did not affect
r
P
Copyright © 1999 by Academic Press. All rightell viability (Fig. 2B), it was used in most of the
xperiments reported here.
Phosphorylation Status of PEA-15 Does Not Alter
Its Effect on TNF-a-Induced Apoptosis
PEA-15 was first characterized in astrocytes in primary
culture as a highly phosphorylated protein (Araujo et al.,
1993). Two phosphorylation sites in PEA-15 have been
identified: a protein kinase C (PKC) site at Ser 104 and a
calcium calmodulin kinase II (CaMKII) site at Ser 116
(Estelle´s et al., 1996) (Fig. 2E). Both of these sites are
phosphorylated in 3T3 cells as well as in astrocytes, as
determined by different migration in 2-D gel electrophore-
sis (Estelle´s and Blau, unpublished observations). To test
whether phosphorylation of PEA-15 was involved in its
enhancement of TNF-a-induced apoptosis, cells expressing
EA-15 with mutations in either or both the PKC and the
aMKII phosphorylation sites were tested. Upon stimula-
ion with TNF-a in the presence of cycloheximide, cells
xpressing the three mutant proteins were not found to
-15 and the double phosphorylation-defective mutant of PEA-15
row 1) or cells expressing wild-type PEA-15 (row 2) or the double
were treated for 0, 3, 4.5, or 6 h with TNF-a in the presence of the
use in caspase-8 activity assays (Fig. 6), cells were photographed toPEA
ells (
w 3),espond differently from cells expressing the wild-type
EA-15, suggesting that the state of phosphorylation of
s of reproduction in any form reserved.
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20 Estelle´s, Charlton, and BlauFIG. 2. Both wild-type PEA-15 and phosphorylation mutants enhance TNF-R1-mediated apoptosis. (A) PEA-15 expression enhances cell
death induced by TNF-a. 3T3–GUS or 3T3–PEA-15 cells were treated with human recombinant TNF-a in the presence of the protein
synthesis inhibitor cycloheximide. After 4 h the medium was changed. 24 h later cells were analyzed by FACS for PI incorporation. An
average of three independent experiments assayed in quadruplicate 6 SD is shown with the percentage of PI-positive cells in 3T3–PEA-15
cells (right bar) shown relative to 3T3–GUS cells (left bar, normalized to 100%). (B) The increase in TNF-a-induced apoptosis mediated by
PEA-15 is blocked by a CrmA-sensitive caspase. 3T3 cells were transduced with a retrovirus expressing the caspase inhibitor gene CrmA
and the marker for puromycin resistance (pBabe–CrmA–Puro). Cells were selected with puromycin and then 3T3 or 3T3–CrmA cells were
transduced with a retrovirus expressing either GUS or both PEA-15 and GUS. 3T3–GUS, 3T3–PEA-15, 3T3–CrmA–GUS, or 3T3–CrmA–
PEA-15 were treated with human recombinant TNF-a in the presence of the protein synthesis inhibitor cycloheximide (gray bars) or left
ntreated (black bars). After 4 h the medium was changed. Cells were analyzed 24 h later by FACS for PI incorporation. A representative
xperiment is shown with percentage of PI-positive cells in samples assayed in quadruplicate 6 SD. (C) PEA-15 expression does not block
F-kB activation. 3T3–GUS or 3T3–PEA-15 were transiently transfected with an NF-kB luciferase reporter construct. Twenty-four hours
after transfection, cells were treated for 6 h with TNF-a and luciferase activity was measured. A representative experiment shows the ratio
of luciferase in TNF-a-treated versus untreated cells. Samples were assayed for luciferase in quadruplicate 6 SD. (D) PEA-15 effect on
NF-a-induced apoptosis is not phosphorylation sensitive. (Top) 3T3 cells were transduced with a retrovirus expressing the selectable
marker (GUS) (lane 1), GUS and the wild-type mouse myc–PEA-15 gene, 3T3–-PEA-15 (lane 2), or GUS and one of the following
phosphorylation defective mutants: 3T3–M1 single point mutation in the PKC site S104A (lane 3); 3T3–M2 single point mutation in the
CaMKII site S116A (lane 4); and 3T3–M3 PKC and CaMKII double mutant (lane 5). Expression of the wild-type and phosphorylation-
defective mutants was verified by immunoblotting analysis using an antibody to PEA-15. (Bottom) Cells were treated with human
recombinant TNF-a in the presence of the protein synthesis inhibitor cycloheximide (gray bars) or cycloheximide alone (black bars) or left
ntreated (white bars). After 4 h the medium was changed and cells were analyzed 24 h later by FACS for PI incorporation. A representative
xperiment is shown with percentage of PI-positive cells in samples assayed in quadruplicate 6 SD. (E) Structure of PEA-15 containing the
ED at its N-terminus and the two serine residues reported to be phosphorylated (S104 and S116).
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21Opposite Effects on Apoptosis via Two Death ReceptorsPEA-15 was not the basis of its physiological effect in this
apoptotic pathway (Figs. 1 and 2D).
PEA-15 Expression Does Not Block NF-kB
ctivation
Activation of the transcription factor NF-kB has been
eported to protect cells from TNF-a-induced cell death
(Beg and Baltimore, 1995; Van Antwerp et al., 1996). Be-
cause PEA-15 expression renders 3T3 cells more sensitive
to TNF-a-induced apoptosis, we investigated whether the
echanism by which cell death is enhanced might involve
nhibition of NF-kB activation. Control and PEA-15-
xpressing cells were transiently transfected with an NF-
kB-responsive luciferase reporter construct, treated with
TNF-a at a concentration previously determined to be
optimal, or left untreated and analyzed for luciferase activ-
ity. TNF-a induced a significant fold increase in luciferase
activity and PEA-15 expression neither increased nor de-
creased this effect (Fig. 2C). These data suggest that NF-kB
FIG. 3. Effect of PEA-15 on Fas-mediated cell death. PEA-15
phosphorylation mutant of PEA-15 does not. 3T3 cells expressing F
M3 (S104A&S116A) (row 3), were treated for 0, 3, 4.5, or 6 h wit
cycloheximide. Prior to harvesting cells for use in caspase-8 activi
death.is not involved in the PEA-15 effect on the TNF-a apoptotic
athway.
Copyright © 1999 by Academic Press. All rightFas-Induced Apoptosis of NIH-3T3 Cells
3T3 cells, like many other types of cells, express low
levels of the receptor Fas and are not sensitive to Fas-
mediated apoptosis. Exposure of the cells to cross-linking
anti-Fas antibody mimics receptor activation by Fas ligand.
Inhibition of protein synthesis by cycloheximide concomi-
tant with treatment with anti-Fas antibodies often renders
cells more sensitive to Fas-induced apoptosis (Arscott et al.,
1997; Natoli et al., 1995; Ni et al., 1994; Rokhlin et al.,
1997). 3T3 cells were genetically engineered by transduc-
tion with a retrovirus encoding both Fas and GUS. Follow-
ing a single infection with the retroviral vector, greater than
90% of cells expressed Fas at 20-fold parental 3T3 cell levels
as determined by FACS. In contrast to parental 3T3 cells,
3T3–Fas cells were highly sensitive to anti-Fas antibody-
induced apoptosis in the presence of cycloheximide exhib-
iting approximately 70% cell death relative to 20% cell
death following exposure only to anti-Fas antibodies (data
not shown). Expression of PEA-15 in 3T3-Fas cells inhibited
anti-Fas antibody-induced apoptosis approximately fivefold
bits apoptosis induced by anti-Fas antibody, while the double
one (row 1), PEA-15 (row 2), or the doubly mutant form of PEA-15,
ti-Fas antibody in the presence of the protein synthesis inhibitor
says (Fig. 6), cells were photographed to document effects on cellinhi
as al
h an(Fig. 4A).
Previous reports have shown that two different pathways
s of reproduction in any form reserved.
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22 Estelle´s, Charlton, and BlauFIG. 4. Wild-type PEA-15, but not phosphorylation mutants, protect cells from Fas-mediated apoptosis. (A) PEA-15 protects 3T3–Fas cells
from Fas-mediated cell death. (Top) 3T3–Fas cells (lane 1) were transduced with a retrovirus expressing murine myc–PEA-15,
pBabe–M-GUS–IRES–myc–PEA-15 (lane 2), and PEA-15 expression was analyzed by Western blot analysis using anti-PEA-15 antibodies.
(Bottom) 3T3–Fas or 3T3–Fas–PEA-15 cells were treated with murine anti-Fas antibody (gray bars) in the presence of the protein synthesis
inhibitor cycloheximide or left untreated (black bars). After 4 h the medium was changed and cells were analyzed 24 h later by FACS for
PI incorporation. A representative experiment is shown with percentage of PI-positive cells in samples assayed in quadruplicate 6 SD. (B)
cl-2 does not protect cells from Fas-induced apoptosis. 3T3–Fas cells were transduced with a retroviral vector expressing Bcl-2 and the
electable marker puromycin (MSCV–Bcl-2–PGK–Puro). After drug selection, the 3T3–Fas cells and 3T3–Fas– Bcl-2 cells were treated with
urine anti-Fas antibody in the presence of the protein synthesis inhibitor cycloheximide (gray bars) or staurosporine (hatched bars) or leftntreated (white bars). Cells were exposed to staurosporine for 24 h. Anti-Fas antibody and cycloheximide were present for 4 h, and then
he medium was changed and cells were analyzed 24 h later by FACS for PI incorporation. A representative experiment is shown with
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
23Opposite Effects on Apoptosis via Two Death Receptorscan mediate Fas signaling to apoptosis (Scaffidi et al., 1998).
One involves a high level of activation of caspase-8 by
recruitment to the DISC at the cell membrane (type I). In
the other, DISC formation is reduced accompanied by
low-level caspase-8 activation, but is enough to cleave and
activate BID, a proapoptotic Bcl-2 family member that
induces cytochrome c release and amplification of the
caspase cascade during apoptosis (type II cells) (Bossy-
Wetzel and Green, 1999; Li et al., 1998). Only in type II cells
does the mitochondrial protein, Bcl-2, block Fas-induced
apoptosis. We investigated whether Fas-induced apoptosis
was sensitive to Bcl-2 by creating a stable cell line that
expressed increased amounts of this molecule following
transduction with a retroviral vector encoding Bcl-2. Bcl-2
did not protect 3T3-Fas cells from Fas-induced apoptosis
(Fig. 4B). In contrast, when cell death was induced by the
protein kinase inhibitor staurosporine that operates via the
type II pathway, Bcl-2 effectively blocked apoptosis (.10-
fold) in accordance with previous reports (Jacobsen et al.,
1996). These findings suggest that NIH-3T3 cells are type I
cells and that caspase-8 is activated by recruitment to the
DISC at the cell membrane.
Expression of the DED-Containing Protein, PEA-15,
Protects Cells from Fas-Induced Apoptosis
To study whether the DED-containing protein PEA-15
could influence Fas-induced apoptosis, cells were stably
transduced with a retrovirus-expressing myc epitope-tagged
PEA-15. Western blot analysis demonstrated a 20-fold
higher level of the protein than the endogenous PEA-15 (Fig.
4A, top), but expression of myc–PEA-15 alone did not affect
cell death (Fig. 4A, bottom). When apoptosis was induced by
cross-linking anti-Fas antibodies, PEA-15 effectively pro-
tected cells from death (Fig. 3); a reduction of approximately
50% cell death to 10%, or 5-fold relative to control cells,
was detectable by FACS measurement of the incorporation
of PI (Fig. 4A).
Increased expression after transient transfection of either
the adapter protein FADD/Mort1 or caspase-8 has previ-
ously been shown to induce apoptosis (Boldin et al., 1995,
1996; Chinnaiyan et al., 1995; Muzio et al., 1996). We found
that expression of each of these two proteins by retroviral
transduction into 3T3 cells also induced apoptosis (data not
shown). PEA-15 protected the cells and decreased the pro-
portion of cells that died. These results suggest that PEA-15
percentage of PI-positive cells in samples assayed in quadruplicate
phosphorylation status. (Top) 3T3–Fas cells (lane 1) were transduc
(lane 2) or one of the following phosphorylation-defective mutant
3T3–Fas–M2 single point mutation in the CaMKII site S116A (lane
of the wild-type and phosphorylation-defective mutants was verified
antibody in the presence of the protein synthesis inhibitor cyclohe
(white bars). After 4 h the medium was changed and cells were ana
experiment is shown with percentage of PI-positive cells in samples as
Copyright © 1999 by Academic Press. All rightacts downstream of FADD/Mort1, possibly at the level of
caspase-8.
The Protective Effect of PEA-15 Is Regulated by
Phosphorylation
To test the potential role of phosphorylation in the
anti-apoptotic effect of PEA-15, the cells expressing the
PEA-15 single and double point mutants described above
were introduced into 3T3–Fas cells by retroviral transduc-
tion. Relative to untreated controls, only wild-type PEA-15
was able to protect cells from apoptosis induced by cross-
linking with anti-Fas antibodies as shown in Figs. 3 and 4C;
only 10% of the cells died. By contrast, phosphorylation-
defective mutants gave results similar to control cells (ca.
70% of cells died), failing to exert any detectable protective
effect. This effect was not due to inhibition of protein
synthesis, since cells treated with cycloheximide alone
were indistinguishable from untreated controls in each
case. Moreover, the effects were not due to differences in
levels of protein expression, since Western blot analysis
revealed similar amounts of wild-type and mutant PEA-15
proteins (Fig. 4C, top). These results indicate that PEA-15
phosphorylation in either or both PKC and CaMKII sites is
critical to the PEA-15 anti-apoptotic effect and that muta-
tion of a single site is sufficient to abrogate the protective
effect of the protein in the cell death pathway.
Protein Interactions
We undertook experiments to examine whether PEA-15
interacts with other known DED-containing proteins at the
receptor complex. To this end, stable cell lines expressing a
flag-tagged FADD protein were generated. Both in the absence
and in the presence of myc–PEA-15, FADD and caspase-8
were found to coimmunoprecipitate in a ligand-dependent
manner, suggesting that increased PEA-15 expression, unlike
the DED-containing protein c-FLIP, did not block FADD and
caspase-8 interaction (Fig. 5A). To assess whether the interac-
tion between FADD and caspase-8 occurred at the receptor
near the cell surface, Fas was immunoprecipitated from cells
using the anti-Fas antibody, and coimmunoprecipitated
FADD and caspase-8 were detected by Western analysis. The
presence of wild-type PEA-15 or the phosphorylation-
defective mutant did not interfere with the formation of the
receptor complex, and caspase-8 and FADD (Fig. 5B) were
. (C) PEA-15 effect on Fas-mediated apoptosis is dependent on its
th a retrovirus expressing the wild-type mouse myc–PEA-15 gene
3–Fas–M1 single point mutation in the PKC site S104A (lane 3);
3T3–Fas–M3 PKC and CaMKII double mutant (lane 5). Expression
mmunoblotting analysis. (Bottom) Cells were treated with anti-Fas
de (gray bars) or cycloheximide alone (black bars) or left untreated6 SD
ed wi
s: 3T
4); or
by i
ximi
lyzed 24 h later by FACS for PI incorporation. A representative
sayed in quadruplicate 6 SD.
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25Opposite Effects on Apoptosis via Two Death Receptorscoimmunoprecipitated with Fas in a ligand-dependent man-
ner. Indeed, in addition to the data presented in Fig. 5, cells
were stimulated with either TNF-a at 100 ng/ml or anti-Fas
ntibody at concentrations of 100 ng/ml or 1 mg/ml for 30
in,1 h, 3 h, and 6 h but no interaction with PEA-15 and the
roteins listed above was detected (data not shown). Thus, we
id not find any evidence for a direct interaction in our
oimmunoprecipitation studies between PEA-15 and Fas (Fig.
B and data not shown) or between PEA-15 and FADD or
aspase-8 (Fig. 5C).
To further test the possibility that PEA-15 interacted
ith either caspase-8 or FADD/Mort1, we used another
pproach. We generated a GST–PEA-15 fusion protein
ound to glutathione–Sepharose beads and incubated it
ith total lysates from 3T3 cells. GST–FADD was used as
control for this procedure. In this assay, like the immu-
oprecipitation experiments above, cellular caspase-8 inter-
cted with GST–FADD, but it did not interact with GST–
EA-15 (Fig. 5D). In addition, cellular PEA-15 did not
nteract with GST–FADD (Fig. 5D).
Thus, the expected FADD/Mort1 and caspase-8 protein
nteractions were observed in both assays. However, inter-
ctions of PEA-15 and FADD/Mort1 or caspase-8 were not
etected by coimmunoprecipitation of PEA-15 from cells or
y interaction with GST–PEA-15 fusion proteins in vitro.
ither the interactions are too labile and cannot be detected
y the methods used here or the interaction of PEA-15 with
hese proteins is indirect, possibly via as yet unidentified
roteins.
Mechanism of Action: PEA-15 Alters Caspase-8
Activity
Since studies of protein interactions with known candi-
dates were uninformative, we performed functional assays
FIG. 5. Protein interactions in the presence of PEA-15. (A) Ne
caspase-8 detected by immunoprecipitation. 3T3 cells were transd
3T3–FADD cells). Populations of 3T3–FADD cells were then trans
and CaMKII double mutant, M3 (S104A & S116A). Cells were indu
of cycloheximide) or left untreated. Flag antibodies were used to
detected by Western blot analysis. Left lane is a total cell lysate of 3
with caspase-8 at the receptor complex. Cells as in (A) were induce
cycloheximide) or left untreated. After lysis, protein G–Sepharose b
tating caspase-8 was detected by western blotting using anti-caspas
anti-flag antibodies in 3T3–FADD cells not expressing PEA-15 (right
caspase-8 and flag–FADD migration. (C) Interaction of PEA-15 wit
in (A) and (B) were induced for 5 min with the cross-linking anti-Fas
antibodies were used to immunoprecipitate myc–PEA-15 and coimm
FADD was immunoprecipitated with flag antibodies in 3T3–FADD
detected by Western blot using anti-myc antibodies (right). Left lan
PEA-15 cells to show caspase-8 and myc–PEA-15 migration. (D
GST-binding reactions. (Left) Total lysates from 3T3–FADD cells w
coupled to glutathione–Sepharose beads and caspase-8 was detected
(total lysate). (Right) Total lysates from 3T3–PEA-15 cells were
Sepharose beads and myc–PEA-15 was detected by immunoblotting usi
left lane (total lysate).
Copyright © 1999 by Academic Press. All righto elucidate the mechanism of action of PEA-15. To test the
eans by which PEA-15 enhances TNF-R1-induced cell
eath but confers protection to Fas-induced cell death,
aspase-8 activity was assayed over time in cells expressing
EA-15 or the double phosphorylation-defective mutant,
ompared to control cells. Caspase-8 activity was signifi-
antly increased in response to TNF-R1 activation in cells
ontaining either PEA-15 or the double phosphorylation
utant of PEA-15 in comparison to control cells (Fig. 6A)
nd the caspase-8 activity pattern in these cells correlated
ith the time course of cell death (Figs. 1, 2D, and 6A). In
ontrast, PEA-15 inhibited caspase-8 enzymatic activity
fter Fas activation, while caspase-8 activity of cells ex-
ressing the double phosphorylation-defective mutant
EA-15 was similar to that of the control cells (Fig. 6B).
his pattern of activity again correlated with the cell death
ate (Figs. 3, 4C, and 6B), suggesting that phosphorylation is
equired for PEA-15 to inhibit caspase-8 activation and
poptosis in response to Fas stimulation. Moreover, these
ata confirmed that the phosphorylation status of PEA-15 is
ritical to its effects on the Fas-mediated but not the
NF-R1-mediated cell death pathway (Figs. 1, 2D, and 6A).
DISCUSSION
In this report we describe a novel bifunctional role for the
phosphoprotein, PEA-15, in two different apoptotic path-
ways in the same cell type. No function has previously been
ascribed to this phosphoprotein, but the presence of a DED
sequence suggests a role in apoptosis (Boldin et al., 1995;
Chinnaiyan et al., 1995). We show here that low-level
expression of PEA-15 inhibits apoptosis mediated by Fas
and promotes apoptosis mediated by TNF-R1, two major
cell death receptors.
wild-type nor mutant PEA-15 blocks interaction of FADD and
with a retroviral vector expressing flag–FADD (PFEV–flag–FADD,
d with a retrovirus expressing wild-type myc–PEA-15 or the PKC
for 5 min with the cross-linking anti-Fas antibody (in the absence
unoprecipitate FADD and coimmunoprecipitated caspase-8 was
ADD cells to show caspase-8 migration. (B) FADD/Mort1 interacts
5 min with the cross-linking anti-Fas antibody (in the absence of
were added, and Fas was immunoprecipitated. Coimmunoprecipi-
ntibodies (left). Coimmunoprecipitating FADD was detected using
t lane of each panel is a total cell lysate of 3T3–FADD cells to show
pase-8 or FADD is not detected by immunoprecipitation. Cells as
body (in the absence of cycloheximide) or left untreated. Anti-myc
precipitated caspase-8 was detected by Western blot analysis (left).
s expressing PEA-15 and coimmunoprecipitated myc–PEA-15 was
ach panel is a total cell lysate of 3T3–FADD or 3T3–FADD–myc–
raction of PEA-15 with caspase-8 or FADD is not detected in
incubated with GST, GST–PEA-15, or GST–FADD fusion proteins
estern blot analysis. Caspase-8 migration is shown in the left lane
bated with GST–FADD fusion proteins coupled to glutathione–ither
uced
duce
ced
imm
T3–F
d for
eads
e-8 a
). Lef
h cas
anti
uno
cell
e of e
) Inte
ere
by W
incung anti-myc antibodies. Migration of myc–PEA-15 is shown in the
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26 Estelle´s, Charlton, and BlauBy what mechanism could the same DED-containing
protein, PEA-15, play a differential role in apoptosis in-
duced by two different cell death receptors that both recruit
the DED-containing proteins FADD/Mort1 and caspase-8
to the receptor complex? The crux of the difference in
function appears to be the phosphorylation of PEA-15 since
FIG. 6. PEA-15 affects caspase-8 activation. (A) Both PEA-15 and
he double phosphorylation-defective PEA-15 mutant increase
aspase-8 activity induced by TNF-R1 activation. Control cells or
ells expressing PEA-15 or the double phosphorylation mutant of
EA-15 (S104A&S116A) were treated for various times with TNF-a
and analyzed for caspase-8 activity using a colorimetric assay. (B)
Expression of PEA-15 inhibits caspase-8 activity induced by Fas
activation. 3T3–Fas cells, 3T3–Fas–PEA-15 cells, or 3T3–Fas–PEA-
15–M3 cells (containing S104A&S116A mutations) were treated for
various times with anti-Fas antibody and analyzed for caspase-8
activity using a colorimetric assay.phosphorylation-defective mutants had opposite effects in
the two cell death pathways. PKC and CaMKII have been
Copyright © 1999 by Academic Press. All righteported to phosphorylate PEA-15 in primary astrocytes in
esponse to noradrenaline and endothelin (Araujo et al.,
993; Kubes et al., 1998) and the same phosphorylated
orms are present in 3T3 cells (Estelle´s and Blau, unpub-
ished observations). A serine to alanine substitution in
ither or both of the PKC and CaMKII sites rendered
EA-15 inactive in protecting cells from Fas-induced
poptosis, but had no effect on its death-inducing activity
ia TNF-R1. Thus, our results suggest that to function in
he Fas pathway, phosphorylation of PEA-15 may be criti-
al, whereas in the TNF-R1 pathway, it is not.
Several lines of evidence presented in this report suggest
hat the point in the two cell death pathways at which
EA-15 exerts its differential effects is at the level of
aspase-8. First, Bcl-2 has previously been shown to inhibit
as-induced apoptosis in type II cells in which DISC forma-
ion and caspase-8 activation are insignificant relative to
he involvement of mitochondria in the activation of the
ownstream cell death machinery (Bossy-Wetzel and
reen, 1999; Li et al., 1998; Scaffidi et al., 1998). Thus, the
ailure of Bcl-2 to protect against Fas-induced apoptosis in
he cells tested here indicates that apoptosis is likely to
roceed in these cells via activation of caspase-8 at the
embrane (type I cells). Second, we found that PEA-15
nhibited apoptosis induced by overexpression either of the
dapter protein, FADD/Mort1, or of caspase-8, which sug-
ests that PEA-15 acts downstream of FADD/Mort1. Third,
he effect of PEA-15 on TNF-a-induced apoptosis did not
involve inhibition of NF-kB which has been reported to
have a protective effect on TNF-R1-induced cell death (Beg
and Baltimore, 1995; Van Antwerp et al., 1996). Fourth,
CrmA, which is known to be a specific inhibitor of
caspase-8 (Tewari and Dixit, 1995), blocked PEA-15 poten-
tiation of TNF-R1-mediated cell death, implying that the
target of PEA-15, direct or indirect, is caspase-8. Finally,
measurement of caspase-8 activity in control cells and in
cells expressing PEA-15 or PEA-15 phosphorylation-
defective mutants differed and correlated well with the
protective or potentiating effects of these proteins in both
Fas- and TNF-R1-mediated apoptotic pathways.
We attempted to identify proteins in the death receptor
signaling complex that might interact with PEA-15. No
interaction between PEA-15 and DED-containing proteins
FADD/Mort1 and/or caspase-8 could be detected. However,
either in the absence or in the presence of PEA-15, ligand-
dependent complexes of Fas, FADD/Mort1, and caspase-8
were observed suggesting either that the interactions with
PEA-15 are too transient or unstable to be detected by
immunoprecipitation or that other proteins that remain to
be identified may serve as intermediates. Indeed, an indirect
mechanism of action, possibly via another as yet unidenti-
fied DED-containing protein, seems likely given the evi-
dence that PEA-15 did not block the interaction of FADD/
Mort1 and caspase-8.
In summary, we have demonstrated a novel dual role for
a DED-containing phosphoprotein, PEA-15, in apoptosis in
the same cell type, a role in which PEA-15 protects against
s of reproduction in any form reserved.
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27Opposite Effects on Apoptosis via Two Death ReceptorsFas-mediated and potentiates TNF-R1-mediated cell death.
Phosphorylation appears to play a critical role in determin-
ing which effect PEA-15 exhibits. Both effects clearly oper-
ate at the level of caspase-8 activity although specific
interacting molecular partners remain to be identified.
PEA-15 is unlike other DED-containing proteins described
thus far in that its expression provides a means by which a
cell can respond differently to two extracellular apoptotic
stimuli. Such proteins are likely to serve an important role
during embryonic and adult development.
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